BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38548753)

  • 1. Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia.
    Spertini C; Bénéchet AP; Birch F; Bellotti A; Román-Trufero M; Arber C; Auner HW; Mitchell RA; Spertini O; Smirnova T
    Cell Death Discov; 2024 Mar; 10(1):157. PubMed ID: 38548753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells.
    Smirnova T; Spertini C; Spertini O
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes.
    Kittan NA; Allen RM; Dhaliwal A; Cavassani KA; Schaller M; Gallagher KA; Carson WF; Mukherjee S; Grembecka J; Cierpicki T; Jarai G; Westwick J; Kunkel SL; Hogaboam CM
    PLoS One; 2013; 8(10):e78045. PubMed ID: 24205083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte macrophage colony stimulating factor exerts dominant effects over macrophage colony stimulating factor during macrophage differentiation in vitro to induce an inflammatory phenotype.
    Petrina M; Alothaimeen T; Bouzeineddine NZ; Trus E; Banete A; Gee K; Basta S
    Inflamm Res; 2024 Feb; 73(2):253-262. PubMed ID: 38158446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma.
    Gutiérrez-González A; Martínez-Moreno M; Samaniego R; Arellano-Sánchez N; Salinas-Muñoz L; Relloso M; Valeri A; Martínez-López J; Corbí ÁL; Hidalgo A; García-Pardo Á; Teixidó J; Sánchez-Mateos P
    Blood; 2016 Nov; 128(18):2241-2252. PubMed ID: 27625360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.
    Estrov Z; Estey EH; Andreeff M; Talpaz M; Kurzrock R; Reading CL; Deisseroth AB; Gutterman JU
    Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin.
    Jaguin M; Houlbert N; Fardel O; Lecureur V
    Cell Immunol; 2013 Jan; 281(1):51-61. PubMed ID: 23454681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIF-Induced Stromal PKCβ/IL8 Is Essential in Human Acute Myeloid Leukemia.
    Abdul-Aziz AM; Shafat MS; Mehta TK; Di Palma F; Lawes MJ; Rushworth SA; Bowles KM
    Cancer Res; 2017 Jan; 77(2):303-311. PubMed ID: 27872094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allostimulatory activity as a criterion of the functional phenotype of human macrophages.
    Yankovskaya AA; Shevela EY; Sakhno LV; Tikhonova MA; Dome AS; Ostanin AA; Chernykh ER
    Hum Immunol; 2019 Oct; 80(10):890-896. PubMed ID: 31447056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Castro BA; Flanigan P; Jahangiri A; Hoffman D; Chen W; Kuang R; De Lay M; Yagnik G; Wagner JR; Mascharak S; Sidorov M; Shrivastav S; Kohanbash G; Okada H; Aghi MK
    Oncogene; 2017 Jun; 36(26):3749-3759. PubMed ID: 28218903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia induces macrophage polarization and re-education toward an M2 phenotype in U87 and U251 glioblastoma models.
    Leblond MM; Gérault AN; Corroyer-Dulmont A; MacKenzie ET; Petit E; Bernaudin M; Valable S
    Oncoimmunology; 2016; 5(1):e1056442. PubMed ID: 26942063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal proteins sustain morphology, function and phenotype in acute myeloid leukemia blasts.
    Bassøe CF; Bruserud O; Pryme IF; Vedeler A
    Leuk Res; 1998 Apr; 22(4):329-39. PubMed ID: 9669838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinate secretion of interleukin-1 beta and granulocyte-macrophage colony-stimulating factor by the blast cells of acute myeloblastic leukemia: role of interleukin-1 as an endogenous inducer.
    Rodriguez-Cimadevilla JC; Beauchemin V; Villeneuve L; Letendre F; Shaw A; Hoang T
    Blood; 1990 Oct; 76(8):1481-9. PubMed ID: 2207323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte-associated Ig-like receptor-1 prevents granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1/PKB alpha activation in primary acute myeloid leukemia cells.
    Zocchi MR; Pellegatta F; Pierri I; Gobbi M; Poggi A
    Eur J Immunol; 2001 Dec; 31(12):3667-75. PubMed ID: 11745387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts.
    Bhalla K; Holladay C; Arlin Z; Grant S; Ibrado AM; Jasiok M
    Blood; 1991 Nov; 78(10):2674-9. PubMed ID: 1824260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia.
    Biethahn S; Alves F; Wilde S; Hiddemann W; Spiekermann K
    Exp Hematol; 1999 May; 27(5):885-94. PubMed ID: 10340405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia.
    Motoji T; Takanashi M; Fuchinoue M; Masuda M; Oshimi K; Mizoguchi H
    Exp Hematol; 1989 Jan; 17(1):56-60. PubMed ID: 2783249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 stimulates proliferation of acute myeloblastic leukemia cells by induction of granulocyte-macrophage colony-stimulating factor release.
    Delwel R; van Buitenen C; Salem M; Bot F; Gillis S; Kaushansky K; Altrock B; Löwenberg B
    Blood; 1989 Aug; 74(2):586-93. PubMed ID: 2665849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DT388-GM-CSF, a novel fusion toxin consisting of a truncated diphtheria toxin fused to human granulocyte-macrophage colony-stimulating factor, prolongs host survival in a SCID mouse model of acute myeloid leukemia.
    Hall PD; Willingham MC; Kreitman RJ; Frankel AE
    Leukemia; 1999 Apr; 13(4):629-33. PubMed ID: 10214872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalase plays a critical role in the CSF-independent survival of human macrophages via regulation of the expression of BCL-2 family.
    Komuro I; Yasuda T; Iwamoto A; Akagawa KS
    J Biol Chem; 2005 Dec; 280(50):41137-45. PubMed ID: 16204228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.